Investing in Innovation Africa (i3), a pan-African initiative for start-ups building the future of healthcare supply chains, has reiterated its commitment to financing African startups in healthcare supply chains. This is even as it is calling for leading innovators to join its second cohort.
Funded by the Bill & Melinda Gates Foundation and sponsored by AmerisourceBergen, Merck Sharpe & Dohme (MSD), Microsoft and Chemonics, i3 is supporting the commercialization of 60 promising early- and growth-stage companies. The programme connects African-led supply chain innovators to donors, industry, and government partners, to power start-ups’ growth and impact. Selected start-ups receive targeted introductions to customers to support commercialization and impact, a $50,000 grant, and tailored investment readiness support. i3 is particularly focused on selecting women-led companies and those operating in Francophone regions.
The first cohort, selected in September 2022, featured 31 innovators enhancing access to health products across more than 24,000 hospitals, clinics, and pharmacies in 26 African countries. To date, the i3 program has facilitated 200+ introductions between the cohort, the sponsors, and potential partners such as USAID, The Global Fund, Benshi.aI, i+Solutions, Chemonics, John Snow Inc., FHI360, Madiro Foundation, government representatives from Nigeria’s Federal Ministry of Health, representatives from Ekiti and Lagos state, and more.